Evidence map›Paper›PMID 40746601›Full record

ArticleFrontiers in oncology2025

CLGB-Net: fusion network for identifying local and global information of lesions in digital mammography images.

Ningxuan Hu, Zhizhen Gao, Zongyu Xie, Lei Li

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ningxuan HuSchool of Medical Imaging, Bengbu Medical University, Anhui, China.
Zhizhen GaoDepartment of Radiology, The First Affiliated Hospital of Bengbu Medical University, Anhui, China.
Zongyu XieDepartment of Radiology, The First Affiliated Hospital of Bengbu Medical University, Anhui, China.
Lei LiSchool of Medical Imaging, Bengbu Medical University, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Worldwide, breast cancer ranks among the cancers with the highest incidence rate. Early diagnosis is crucial to improve the survival rate of patients. Digital Mammography (DM) is widely used for breast cancer diagnosis. The disadvantage is that DM relies too much on the doctor's experience, which can easily lead to missed diagnosis and misdiagnosis. In order to address the shortcomings of traditional methods, a CLGB-Net deep learning model integrating local and global information is proposed for the early screening of breast cancer. Four network architectures are integrated into the CLGB-Net model: ResNet-50, Swin Transformer, Feature Pyramid Network (FPN), and Class Activation Mapping (CAM). ResNet-50 is used to extract local features. The Swin Transformer is utilized to capture global contextual information and extract global features. FPN achieves efficient fusion of multi-scale features. CAM generates a class activation weight matrix to weight the feature map, thereby enhancing the sensitivity and classification performance of the model to key regions. In breast cancer early screening, the CLGB-Net demonstrates the following performance metrics: a precision of 0.900, recall of 0.935, F1-score of 0.900, and final accuracy of 0.904. Experimental data from 3,552 samples, including normal, benign, and malignant cases, support these results. The precision of this model was improved by 0.182, 0.038, 0.023, and 0.021 compared to ResNet-50, ResNet-101, Vit Transformer, and Swin Transformer, respectively. The CLGB-Net model is capable of capturing both local and global information, particularly in terms of sensitivity to subtle details. It significantly improves the accuracy and robustness of identifying lesions in mammography images and reduces the risk of missed diagnosis and misdiagnosis.

Indexed as

breast cancerCADCLGB-Netdeep learningearly screening

Identifiers

PMID40746601
PMCPMC12310654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.